SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-082789
Filing Date
2020-07-10
Accepted
2020-07-10 17:17:15
Documents
3
Period of Report
2020-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2024558-1_8k.htm 8-K 27972
2 EXHIBIT 10.1 tm2024558d1_ex10-1.htm EX-10.1 58369
3 EXHIBIT 10.2 tm2024558d1_ex10-2.htm EX-10.2 64051
  Complete submission text file 0001104659-20-082789.txt   151783
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 201023803
SIC: 2834 Pharmaceutical Preparations